Nevertheless, we recently found robust cognitive improvement across several cognitive domains in response to EPO vs. saline treatment in a group of only partially remitted patients with BD [14], suggesting that full remission is not necessary for cognitive benefits of an intervention per se. The gene discussed is EPO; the disease is Behcet disease.